Smith & Nephew Blames Competition, Katrina For Low Orthopedic Sales
This article was originally published in The Gray Sheet
Executive Summary
Smith & Nephew will lower its 2005 revenue guidance to account for the dual impact of new orthopedic products from competitors and Hurricane Katrina
You may also be interested in...
Mentor’s Stock Jumps In Q3 On Silicone Implant “Approvable” Letter
FDA's "approvable" letter to Mentor for the Memory Gel silicone breast implants drove the firm's stock up 32.6% to $55.01 for the quarter, but investor tunnel-vision could keep future stock movement tied to FDA's final decision
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.